Literatur
- 01
Dall L .
et al .
Cutis.
2005;
75(3)
177-180
- 02
Wilson R .
et al .
Chest.
2004;
125(3)
953-964
01 A multicentre, multinational, prospective, randomised, double-blind study to compare
the effectiveness of Moxifloxacin Oral tablets to Standard oral antibiotic regimen
given as firstline therapy in out-patients with Acute Infective exacerbations of Chronic
bronchitis
02 Avalox®, Bayer Vital GmbH
03 Comparing Successful treatment outcomes of Avalox to standard treatments adds Value
for the patient and generates Economic profit for society
